Comparative Study of Antithrombotic Effect of a Low Molecular Weight Heparin and Unfractionated Heparin in an ex Vivo Model of Deep Arterial Injury

By Roque M.   Rauch U.   Reis E.D.   Chesebro J.H.   Fuster V.   Badimon J.J.  

Thrombosis Research, Vol. 98, Iss. 6, 2000-06 ,pp. : 499-505

Elsevier

Access to resources Recommend Favorite

Signs of thrombin generation in pediatric cardiac catheterization with unfractionated heparin bolus or subcutaneous low molecular weight heparin for antithrombotic cover

By Roschitz B.   Beitzke A.   Gamillscheg A.   Sudi K.   Koestenberger M.   Leschnik B.   Muntean W.  

Thrombosis Research, Vol. 111, Iss. 6, 2003-01 ,pp. : 335-341

Elsevier

Access to resources Recommend Favorite

INTERACTION OF A NEW DEPOLYMERIZED HOLOTHURIAN GLYCOSAMINOGLYCAN WITH PROTEINS IN HUMAN PLASMA

By Minamiguchi K.   Nagase H.   Kitazato K.T.   Kitazato K.  

Thrombosis Research, Vol. 83, Iss. 3, 1996-08 ,pp. : 253-264

Elsevier

Access to resources Recommend Favorite

ENOXAPARIN, A LOW-MOLECULAR-WEIGHT HEPARIN SUPPRESSES PROTHROMBIN ACTIVATION MORE EFFECTIVELY THAN UNFRACTIONATED HEPARIN IN PATIENTS TREATED FOR VENOUS THROMBOEMBOLISM

By Grosset A.B.   Spiro T.E.   Beynon J.   Rodgers G.M.  

Thrombosis Research, Vol. 86, Iss. 5, 1997-06 ,pp. : 349-354

Elsevier

Access to resources Recommend Favorite

VERY LOW DOSES OF UNFRACTIONATED HEPARIN POTENTIATE THE ANTI-Xa ACTIVITY OF LOW MOLECULAR WEIGHT HEPARIN (ENOXAPARIN)

By Perez-Requejo J.L.   Lucena-Solano O.   Perez-Garcia M.   Santarelli M.T.  

Thrombosis Research, Vol. 85, Iss. 3, 1997-02 ,pp. : 259-265

Elsevier

Access to resources Recommend Favorite